GH1 and epilepsy: Other substances like recombinant human growth hormone (NCT04003207, completed phase 2 trial), OXT (NCT02710084, completed phase 2 trial, undergoing peer-review), Q10 Ubiquinol (NCT04312152), and the inhibitor of the RAS/RAF/MAPK pathway AMO-01 (NCT03493607, PMDS with epilepsy) are currently investigated or undergo peer-review for publication.